Catalyst Wire Dossier Catalyst Wire Dossier

OK-101

· Okyo Pharma Ltd
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OK-101, covering 2024-02-09 to 2025-08-15. Get the full timeline:

Most recent: Clinical Trial Update: The Study Assessing the Safety and Efficacy of OK-101 Treatment in Subjects With Neuropathic Corneal Pain [Phase 2]

See pricing